设计和优化长期COVID的临床试验

Julia Moore Vogel1, Beth Pollack2, Ezra Spier3

  • 1Scripps Research Translational Institute, Scripps Research, La Jolla, CA, United States of America; Patient-Led Research Collaborative, United States of America.

Life sciences
|August 14, 2024
PubMed
概括

长期COVID的临床试验不足,通常专注于未经证实的非药物治疗方法. 优先考虑药物干预和严格,可访问的研究设计对于理解和治疗这种慢性疾病至关重要.